Roots Analysishas done a detailed study on Gene Switch Market, 2023-2035, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
Key Market Insights
§Presently, close to 50 gene switch platforms are being developed for various applications in adoptive cell therapies (ACT), including CAR-Ts, TCRs and gene therapies; majority of them are protein-based gene switches
§Various small molecules, including rimiducid, rapamycin and dasatinib, are being investigated to design safety switch for ACTs; management of treatment related toxicity has emerged as the key application of such platforms
§The current market landscape is fragmented, featuring the presence of both new entrants and established players; presently, majority of the gene switch platform developers are based in North America
§In pursuit of gaining a competitive edge, gene switch developers are presently undertaking several initiatives to expand their existing capabilities and augment respective product portfolios
§The growing interest in this domain is evident from the rise in licensing agreements over the last few years; majority of such deals were signed between players based in North America
§Several investors, having realized the opportunity within this domain, have invested over USD 3.5 billion across various funding rounds in the past five years
§Scientific articles being published for gene switch, reflect the growing research efforts of various industry and academic stakeholders; majority of the authors are affiliated to organizations based in North America
§More than 360 patents have been filed / granted by various stakeholders in order to protect the intellectual property generated within this field since 2014
§Based on historical trends, we expect a steady growth in the licensing of gene switch platforms, in order to meet the growing demand for safe and effective gene therapies
§The gene switch market is expected to grow at a CAGR of 11.5% till 2035; the overall opportunity is anticipated to be well distributed across various segments, such as types of target therapies, application areas and key regions
Roots Analysisis a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.